Virginia Tech researchers have shown that memory loss in aging may be reversible. Using CRISPR tools, they corrected molecular disruptions in the hippocampus and amygdala, restoring memory in older ...
Q3 2025 Management View CEO Shankar Musunuri highlighted the company's rapid progress on its modifier gene therapy platform, noting "in just over 3 years, we brought our lead candidate, OCU400, from ...
NexCAR19, the world’s first humanised CAR-T therapy developed in India, has made gene therapies affordable and accessible ...
The government has extended financial support to ImmunoAct to expand gene delivery systems, making breakthrough cancer treatments more affordable. Clinical trials of CAR-T therapy have been promising ...
The two main approaches for discovering disease genes reveal distinct aspects of biology, a new study shows. While both ...
Researchers at Mount Sinai have identified the Cyclin A2 gene, which reactivates the human heart's natural healing ability. This gene, active in fetal ...
Q3 2025 Management View CEO Jerrell Shelton highlighted double-digit growth in both Life Sciences Services and Life Sciences Product segments, noting "revenue from our support of commercial cell and ...